The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Kinzalkomb 80 mg/12.5 mg tablets

80 mg/12.5 milligram(s) Tablet

Bayer AGEU/1/02/214/006-010

Main Information

Trade NameKinzalkomb 80 mg/12.5 mg tablets
Active SubstancesTelmisartan
Hydrochlorothiazide
Strength80 mg/12.5 milligram(s)
Dosage FormTablet
Licence HolderBayer AG
Licence NumberEU/1/02/214/006-010

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued19/04/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply Status*** AWAITING VALUE ***
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0050-081-039
Interchangeable List DocumentPDF of Interchangeable List
« Back